Highlights from the International Myeloma Society (IMS) annual meeting 2025Conferences, Myeloma24 September 2025
Join our upcoming MPE and ASCERTAIN webinar on cost-effectiveness analysisMPE, Myeloma23 September 2025
Shape your myeloma care: New MPE research highlights the power of shared decision-making in myeloma careMPE, Myeloma, Patient evidence2 September 2025
The European Commission grants final authorisation for belantamab mafodotin (Blenrep®) combinations for relapsed/refractory myeloma patientsMyeloma, News25 July 2025
New guidelines for the treatment and the management of myeloma and smouldering myelomaMyeloma, News14 July 2025
EMA CHMP gives positive opinion on daratumumab use in smouldering myeloma patients with high risk of developing myelomaAccess, Myeloma27 June 2025
